| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
1994 Consensus Conference on Acute GVHD Grading.
|
Bone Marrow Transplant
|
1995
|
24.01
|
|
2
|
Hematopoietic stem-cell transplantation.
|
N Engl J Med
|
2006
|
10.45
|
|
3
|
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
|
Blood
|
2007
|
9.82
|
|
4
|
Graft-versus-leukemia reactions after bone marrow transplantation.
|
Blood
|
1990
|
7.11
|
|
5
|
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.
|
Biol Blood Marrow Transplant
|
2008
|
7.10
|
|
6
|
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.
|
Blood
|
2011
|
4.45
|
|
7
|
Dose escalation methods in phase I cancer clinical trials.
|
J Natl Cancer Inst
|
2009
|
4.36
|
|
8
|
Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
|
J Clin Oncol
|
2005
|
3.81
|
|
9
|
Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide.
|
Blood
|
2001
|
2.49
|
|
10
|
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
|
Biol Blood Marrow Transplant
|
2008
|
2.15
|
|
11
|
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.
|
Blood
|
2010
|
1.99
|
|
12
|
Cyclophosphamide-induced immunological tolerance: an overview.
|
Immunobiology
|
1996
|
1.72
|
|
13
|
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.
|
Blood
|
2010
|
1.56
|
|
14
|
Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
|
Am J Hematol
|
2013
|
1.48
|
|
15
|
Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation.
|
Biol Blood Marrow Transplant
|
2002
|
1.38
|
|
16
|
Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
|
Bone Marrow Transplant
|
2007
|
1.34
|
|
17
|
Acute myeloid leukemia, version 2.2013.
|
J Natl Compr Canc Netw
|
2013
|
1.26
|
|
18
|
Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs.
|
Clin Exp Immunol
|
2002
|
1.21
|
|
19
|
Non-Hodgkin's lymphomas, version 1.2013.
|
J Natl Compr Canc Netw
|
2013
|
1.20
|
|
20
|
Myelodysplastic syndromes: clinical practice guidelines in oncology.
|
J Natl Compr Canc Netw
|
2013
|
1.12
|
|
21
|
Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
|
J Immunol
|
1991
|
1.10
|
|
22
|
Chronic Myelogenous Leukemia, Version 1.2014.
|
J Natl Compr Canc Netw
|
2013
|
1.07
|
|
23
|
Increased frequency of TCR gamma delta + T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia.
|
J Hematother
|
1996
|
0.99
|
|
24
|
gammadelta T cells: a new frontier for immunotherapy?
|
Biol Blood Marrow Transplant
|
2005
|
0.98
|
|
25
|
Acute lymphoblastic leukemia.
|
J Natl Compr Canc Netw
|
2012
|
0.93
|
|
26
|
New approaches to graft engineering for haploidentical bone marrow transplantation.
|
Semin Oncol
|
2012
|
0.92
|
|
27
|
Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies.
|
Clin Adv Hematol Oncol
|
2005
|
0.92
|
|
28
|
Clinical relevance of natural killer cells following hematopoietic stem cell transplantation.
|
J Cancer
|
2012
|
0.91
|
|
29
|
Hodgkin lymphoma.
|
J Natl Compr Canc Netw
|
2011
|
0.88
|
|
30
|
Influence of T cell depletion method on circulating gammadelta T cell reconstitution and potential role in the graft-versus-leukemia effect.
|
Cytotherapy
|
1999
|
0.83
|
|
31
|
New strategies for haploidentical transplantation.
|
Pediatr Res
|
2012
|
0.78
|
|
32
|
Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
|
Bone Marrow Transplant
|
1990
|
0.78
|
|
33
|
Haploidentical hematopoietic stem-cell transplantation in adults.
|
Bone Marrow Res
|
2011
|
0.75
|